相似文献
1
Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses.
J Nutr. 2004 Sep;134(9):2464S-2468S. doi: 10.1093/jn/134.9.2464S.
2
Heart and liver fatty acid binding proteins and the metabolic syndrome.
Curr Hypertens Rep. 2005 Dec;7(6):401-6. doi: 10.1007/s11906-005-0033-0.
3
Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome.
Curr Atheroscler Rep. 2007 Sep;9(3):222-9. doi: 10.1007/s11883-007-0023-6.
4
The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis.
Curr Opin Lipidol. 2005 Oct;16(5):543-8. doi: 10.1097/01.mol.0000180166.08196.07.
5
Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.
Cell Metab. 2005 Feb;1(2):107-19. doi: 10.1016/j.cmet.2004.12.008.
6
Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population.
BMC Med Genomics. 2013 Mar 19;6:9. doi: 10.1186/1755-8794-6-9.
7
The emerging functions and mechanisms of mammalian fatty acid-binding proteins.
Annu Rev Nutr. 2008;28:73-95. doi: 10.1146/annurev.nutr.27.061406.093710.
8
Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers.
Gene. 2018 Nov 15;676:171-183. doi: 10.1016/j.gene.2018.07.035. Epub 2018 Jul 18.
9
The binding affinity of fatty acid-binding proteins from human, pig and rat liver for different fluorescent fatty acids and other ligands.
Int J Biochem. 1989;21(4):407-18. doi: 10.1016/0020-711x(89)90365-0.
10
Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands.
Mol Cell Biochem. 2002 Oct;239(1-2):35-43.
引用本文的文献
1
Long-term benefits of TUDCA supplement in ARSACS zebrafish model.
Sci Rep. 2025 Jul 14;15(1):25429. doi: 10.1038/s41598-025-10850-0.
2
Potential mechanisms and therapeutic effect of dietary resveratrol supplementation on the spleen organ of chicken in chronic unpredictable mild stress transcriptomic analysis.
Poult Sci. 2025 Apr;104(4):104940. doi: 10.1016/j.psj.2025.104940. Epub 2025 Feb 21.
3
Fatty Acid Binding Protein 4 Could Be a Linking Biomarker Between Periodontitis and Systemic Diseases.
Biomedicines. 2025 Feb 7;13(2):402. doi: 10.3390/biomedicines13020402.
4
Assessment of Serum FABP-4 Levels in Hypothyroidism Patients: A Comparative Analysis With a Control Group and Their Correlation With Liver Function Tests and Biochemical Factors.
Endocrinol Diabetes Metab. 2024 Nov;7(6):e70011. doi: 10.1002/edm2.70011.
5
Proteome profiling reveals opportunities to investigate biomarkers of oxidative stress and immune responses in blubber biopsies from free-ranging baleen whales.
Conserv Physiol. 2024 Aug 19;12(1):coae059. doi: 10.1093/conphys/coae059. eCollection 2024.
6
MicroRNA-21 modulates brown adipose tissue adipogenesis and thermogenesis in a mouse model of polycystic ovary syndrome.
Biol Sex Differ. 2024 Jul 10;15(1):53. doi: 10.1186/s13293-024-00630-2.
7
Modulation of mitochondrial activity by sugarcane (Saccharum officinarum L.) top extract and its bioactive polyphenols: a comprehensive transcriptomics analysis in C2C12 myotubes and HepG2 hepatocytes.
Nat Prod Bioprospect. 2024 Jan 5;14(1):2. doi: 10.1007/s13659-023-00423-x.
8
FABP7 drives an inflammatory response in human astrocytes and is upregulated in Alzheimer's disease.
Geroscience. 2024 Apr;46(2):1607-1625. doi: 10.1007/s11357-023-00916-0. Epub 2023 Sep 9.
9
Associations of three thermogenic adipokines with metabolic syndrome in obese and non-obese populations from the China plateau: the China Multi-Ethnic Cohort.
BMJ Open. 2023 Jul 25;13(7):e066789. doi: 10.1136/bmjopen-2022-066789.
10
AM-879, a PPARy non-agonist and Ser273 phosphorylation blocker, promotes insulin sensitivity without adverse effects in mice.
Metabol Open. 2022 Dec 21;17:100221. doi: 10.1016/j.metop.2022.100221. eCollection 2023 Mar.
本文引用的文献
1
Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S17-21. doi: 10.1038/sj.ijo.0802494.
2
Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene.
J Biol Chem. 2003 Jun 13;278(24):21429-38. doi: 10.1074/jbc.M300287200. Epub 2003 Apr 1.
3
Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
Nature. 2003 Mar 13;422(6928):173-6. doi: 10.1038/nature01478. Epub 2003 Feb 23.
4
Role of the fatty acid binding protein mal1 in obesity and insulin resistance.
Diabetes. 2003 Feb;52(2):300-7. doi: 10.2337/diabetes.52.2.300.
5
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.
Nat Med. 2003 Feb;9(2):213-9. doi: 10.1038/nm820. Epub 2003 Jan 13.
6
Preadipocyte conversion to macrophage. Evidence of plasticity.
J Biol Chem. 2003 Mar 14;278(11):9850-5. doi: 10.1074/jbc.M210811200. Epub 2003 Jan 7.
7
Analysis on the phenotype of E-FABP-gene knockout mice.
Mol Cell Biochem. 2002 Oct;239(1-2):83-6.
8
A central role for JNK in obesity and insulin resistance.
Nature. 2002 Nov 21;420(6913):333-6. doi: 10.1038/nature01137.
9
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages.
Atherosclerosis. 2002 Dec;165(2):259-69. doi: 10.1016/s0021-9150(02)00305-2.
10
Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia.
Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1686-91. doi: 10.1161/01.atv.0000033090.81345.e6.
Zotero 插件